LGBTQ+ Healthcare Disparaties and Respiratory Care Research - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Healthcare Inequities in the LGBTQ+ Community and Investigations in Respiratory Care

  • By

  • RC Central Editorial Team

  • June 11, 2026

Share

Clinical Scorecard: Healthcare Inequities in the LGBTQ+ Community and Investigations in Respiratory Care

At a Glance

CategoryDetail
Condition
Key MechanismsHigher rates of asthma and barriers to COPD diagnosis and management (source needed)
Target Population
Care Setting

Key Highlights

  • Elevated asthma rates among sexual minority populations (source needed)
  • Barriers to COPD diagnosis and treatment for LGBTQ+ individuals (source needed)
  • Underrepresentation of LGBTQ+ individuals in respiratory health research (source needed)
  • Disparities in asthma prevalence linked to smoking and obesity (source needed)
  • Need for more research on COPD in LGBTQ+ populations (source needed)

Guideline-Based Recommendations

Diagnosis

  • Recognize the higher likelihood of asthma in LGBTQ+ individuals, particularly among smokers and those with obesity (source needed)

Management

  • Address barriers to healthcare access for LGBTQ+ patients (source needed)

Monitoring & Follow-up

  • Monitor respiratory health outcomes in LGBTQ+ populations (source needed)

Risks

  • Consider the impact of smoking, depression, and anxiety on respiratory health (source needed)

Patient & Prescribing Data

Tailor treatment approaches to address specific needs and disparities (source needed)

Clinical Best Practices

  • Incorporate LGBTQ+ health disparities into clinical training (source needed)
  • Advocate for more inclusive research in respiratory health (source needed)
  • Engage LGBTQ+ patients in discussions about their respiratory health needs (source needed)

Related Resources & Content

Original Source(s)

LGBTQ+ Healthcare Disparaties and Respiratory Care Research

  • by RC Central Editorial Team

  • June 11, 2026

Related Content

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Tree Canopy Gains Linked to Lower Mortality

The association was most pronounced in Chicago’s hottest neighborhoods, where canopy losses were linked to higher predicted mortality.

Does Pediatric Readiness Reduce ED Imaging?

Hospitals with stronger pediatric emergency capability used less imaging overall, but differences by insurance status and race and ethnicity remained.